Cargando…
During hormone depletion or tamoxifen treatment of breast cancer cells the estrogen receptor apoprotein supports cell cycling through the retinoic acid receptor α1 apoprotein
INTRODUCTION: Current hormonal adjuvant therapies for breast cancer including tamoxifen treatment and estrogen depletion are overall tumoristatic and are severely limited by the frequent recurrence of the tumors. Regardless of the resistance mechanism, development and progression of the resistant tu...
Autores principales: | Salazar, Marcela D, Ratnam, Maya, Patki, Mugdha, Kisovic, Ivana, Trumbly, Robert, Iman, Mohamed, Ratnam, Manohar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109587/ https://www.ncbi.nlm.nih.gov/pubmed/21299862 http://dx.doi.org/10.1186/bcr2827 |
Ejemplares similares
-
Apoprotein E and Reverse Cholesterol Transport
por: Getz, Godfrey S., et al.
Publicado: (2018) -
Role of the short isoform of the progesterone receptor in breast cancer cell invasiveness at estrogen and progesterone levels in the pre- and post-menopausal ranges
por: McFall, Thomas, et al.
Publicado: (2015) -
Modulation of apoprotein E secretion in response to receptor-mediated endocytosis in resident and inflammatory macrophages
Publicado: (1984) -
Subcellular localization of B apoprotein of plasma lipoproteins in rat liver
Publicado: (1976) -
Apoproteins E, A-I, and SAA in Macrophage Pathobiology Related to Atherogenesis
por: Getz, Godfrey S., et al.
Publicado: (2019)